Actively Recruiting
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
Led by University of California, Davis · Updated on 2025-09-25
4000
Participants Needed
1
Research Sites
299 weeks
Total Duration
On this page
Sponsors
U
University of California, Davis
Lead Sponsor
C
Cancer Registry of Greater California
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objectives of the proposed study are to develop and evaluate protocols for ethnic/racial minority-specific research using cancer registry data. In conjunction with the Cancer Registry of Greater California (CRGC), the investigators have developed procedures to identify, recruit, and survey ethnic/racial minority patients with MM. To pilot the study, the investigators aim initially to test the feasibility of this protocol by contacting 400 eligible patients (100 African Americans, 100 Latinos, 100 Asian American/Native Hawaiian/Pacific Islander-AANHPI and 100 non-Hispanic Whites as a comparison group) to conduct a pilot survey through which will ascertain etiological and survival-related factors for MM. Ultimately, the investigators hope the findings from this pilot will yield insight into the best practices for recruiting minorities with MM and serve as the basis for larger population-based studies of MM etiology and survival. The next phase of this study is to expand the study to all 3 California Cancer Registries, including the Greater Bay Area Cancer Registry and the Los Angeles Cancer Surveillance Program and Cancer Registry of Greater California. We will increase the sample size to recruit atleast 1000 participants per racial/ethnic group. We will also request to increase the scope of the study to also continue a survivorship cohort.
CONDITIONS
Official Title
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with a first primary, pathologically confirmed case of Multiple Myeloma within the previous 5 years
- At least 21 years of age at the time of diagnosis
- Diagnosed in one of the 48 counties in California
- Participant must be alive
- Identify as African American, Latino, Asian American/Native Hawaiian/Pacific Islander, or Non-Hispanic White
You will not qualify if you...
- Not diagnosed with Multiple Myeloma
- Under the age of 21
- Pregnant
- Prisoner
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California Davis Comprehensive Cancer Center
Sacramento, California, United States, 95817
Actively Recruiting
Research Team
L
Luis Carvajal-Carmona, PhD
CONTACT
A
Angelica Perez, BS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here